Hunan Hansen Pharmaceutical Co Ltd
SZSE:002412

Watchlist Manager
Hunan Hansen Pharmaceutical Co Ltd Logo
Hunan Hansen Pharmaceutical Co Ltd
SZSE:002412
Watchlist
Price: 6.79 CNY -2.16%
Market Cap: ¥3.4B

Profitability Summary

Hunan Hansen Pharmaceutical Co Ltd's profitability score is 55/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

55/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

55/100
Profitability
Score
55/100
Profitability
Score

Margins

Earnings Waterfall
Hunan Hansen Pharmaceutical Co Ltd

Margins Comparison
Hunan Hansen Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Hunan Hansen Pharmaceutical Co Ltd
SZSE:002412
3.4B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Hunan Hansen Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Hunan Hansen Pharmaceutical Co Ltd
SZSE:002412
3.4B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Hunan Hansen Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate